Home Featured Page 122

Featured

Latest

Erica Rex: Scientific Integrity, Psychedelic Research, and the Religious Leader Study

Pα+ Psychedelic Bulletin #203: Norway Considers Funding Off-Label Ketamine for TRD; Longevity Crowd Hypes Psilocybin Study; Will State-Legal Psychedelics Eat Psychedelic Pharma’s Lunch?

Psychedelic Funding Update: Q2 2025

Daniel Pinchbeck – From Cultural Catalyst to Capitalist Co-option: Reflections on Psychedelic Science, AI, and Idealist Monism

From Senate to Psychedelics: Kyrsten Sinema’s Ibogaine Advocacy Playbook

COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights

Psychedelic Research Bulletin: October 2022

BREAKING: COMPASS Pathways Phase 2b Psilocybin Trial Published in NEJM

Considering a Career in Psychedelics? Here’s How to Get Started.

Free Webinar – NueLife: Empowering Patients with At-Home Ketamine Therapy

Apex Labs Granted Approval for North America’s First Take Home Psilocybin...

ENOSIS THERAPEUTICS AND OVID CLINICS ANNOUNCE PARTNERSHIP TO LAUNCH WORLD’S FIRST...

Lusaris Therapeutics Launches with $60 Million Series A Financing to Redefine...

atai Life Sciences to Participate in November Investor Events & Healthcare...

PharmaTher Enters into Exclusive Option Agreement with Case Western Reserve University...

1...121122123...292 Page 122 of 292

EDITOR PICKS

Erica Rex: Scientific Integrity, Psychedelic Research, and the Religious Leader Study

Pα+ Psychedelic Bulletin #203: Norway Considers Funding Off-Label Ketamine for TRD;...

Psychedelic Funding Update: Q2 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Erica Rex: Scientific Integrity, Psychedelic Research, and the Religious Leader Study

Pα+ Psychedelic Bulletin #203: Norway Considers Funding Off-Label Ketamine for TRD; Longevity Crowd Hypes Psilocybin Study; Will State-Legal Psychedelics Eat Psychedelic Pharma’s Lunch?

Psychedelic Funding Update: Q2 2025

Daniel Pinchbeck – From Cultural Catalyst to Capitalist Co-option: Reflections on Psychedelic Science, AI, and Idealist Monism

From Senate to Psychedelics: Kyrsten Sinema’s Ibogaine Advocacy Playbook

COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights

Psychedelic Research Bulletin: October 2022

BREAKING: COMPASS Pathways Phase 2b Psilocybin Trial Published in NEJM

Considering a Career in Psychedelics? Here’s How to Get Started.

Free Webinar – NueLife: Empowering Patients with At-Home Ketamine Therapy

Apex Labs Granted Approval for North America’s First Take Home Psilocybin...

ENOSIS THERAPEUTICS AND OVID CLINICS ANNOUNCE PARTNERSHIP TO LAUNCH WORLD’S FIRST...

Lusaris Therapeutics Launches with $60 Million Series A Financing to Redefine...

atai Life Sciences to Participate in November Investor Events & Healthcare...

PharmaTher Enters into Exclusive Option Agreement with Case Western Reserve University...

EDITOR PICKS

Erica Rex: Scientific Integrity, Psychedelic Research, and the Religious Leader Study

Pα+ Psychedelic Bulletin #203: Norway Considers Funding Off-Label Ketamine for TRD;...

Psychedelic Funding Update: Q2 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY